Next up we should have a webinar to outline the trial design, recruitment and timelines as indicated by the company, now that ethics approval is obtained.
Ann: Paradigm Secures Ethics Approval for Phase 3 Trial, page-28
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.010(3.08%) |
Mkt cap ! $122.6M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 35.0¢ | 31.5¢ | $418.4K | 1.266M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 92499 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 63097 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PAR (ASX) Chart |